Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Fortiline, LLC, a company that distributes ductile iron pipe, fittings and accessories throughout much of the United States, illegally invited a competitor to collude on prices. Under the FTC order, Fortiline is barred from entering into, attempting to […]
Tag Archives: Bureau of Competition Competition
FTC Requests Public Comment on Application from HeidelbergCement AG and Italcementi S.p.A. to Approve Divestiture of Cement Facility
The Federal Trade Commission is currently accepting public comments on an application from HeidelbergCement AG and Italcementi S.p.A. to sell the Martinsburg, W.Va.-based Martinsburg Cement Business. The divestiture is required by the FTC’s August 2016 order settling charges that the $4.2 billion merger of Heidelberg and Italcementi would likely harm competition in five regional markets […]
FTC Approves Final Order Preserving Competition in Markets for 79 Pharmaceutical Products
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Teva Pharmaceutical Industries Ltd.’s $40.5 billion acquisition of Allergan plc’s generic pharmaceutical business would be anticompetitive. Under the order, first announced in July 2016, Teva is required to divest the rights and assets related to 79 pharmaceutical products […]
FTC Approves American Air Liquide Holdings, Inc.’s Application to Divest Assets to Matheson Tri-Gas, Inc.
Following a public comment period, the Federal Trade Commission has approved an application from American Air Liquide Holdings, Inc. to sell some of its assets to Matheson Tri-Gas, Inc., a Delaware-based subsidiary of Taiyo Nippon Sаnso Corporation of Japan. The divestiture is required by the FTC’s July 2016 final order settling charges that the $13.4 […]
FTC Requires ON Semiconductor Corporation to Divest Its Ignition IGBT Semiconductor Business as a Condition of Acquiring Fairchild Semiconductor International, Inc.
ON Semiconductor Corporation has agreed to sell its Ignition IGBT business in order to settle FTC charges that its proposed $2.4 billion acquisition of Fairchild Semiconductor International, Inc. is anticompetitive. According to the complaint, the merged company would have a combined share of over 60 percent in the worldwide market for Insulated-Gate Bipolar Transistors specifically […]
FTC Approves Final Order Preserving Competition for Customers of Aluminum Beverage Cans
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Ball Corporation’s proposed $8.4 billion acquisition of Rexam PLC would likely be anticompetitive. Under the order, first announced in June 2016, the companies are required to divest eight aluminum can plants and related assets in the United States […]
FTC Approves Final Order Preserving Competition In Five Regional U.S. Markets for Cement
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the proposed $4.2 billion merger of German cement producer HeidelbergCement AG and Italian producer Italcementi S.p.A. would likely be anticompetitive. Under the order, first announced in June 2016, the companies are required to divest to an FTC-approved buyer […]
Investment Trust to Pay $480,000 to Settle FTC Charges It Violated U.S. Premerger Notification Requirements
Investment trust Caledonia Investments plc has agreed to pay $480,000 in civil penalties to resolve Federal Trade Commission allegations that it violated federal premerger reporting laws by failing to report its purchase in 2014 of voting shares in the helicopter services company Bristow Group, Inc. According to the complaint, in June 2008, Caledonia first acquired […]
FTC Requires Teva to Divest Over 75 Generic Drugs to Settle Competition Concerns Related to its Acquisition of Allergan’s Generic Business
Teva Pharmaceutical Industries Ltd. has agreed to sell the rights and assets related to 79 pharmaceutical products to settle FTC charges that its proposed $40.5 billion acquisition of Allergan plc’s generic pharmaceutical business would be anticompetitive. The remedy requires Teva to divest the drug portfolio to eleven firms, and marks the largest drug divestiture order […]
As a Condition of Acquiring Meda, FTC Requires Mylan to Divest Rights to Two Generic Drugs, One for Muscle Spasms and Stiffness, the other for Epilepsy
Mylan Inc. has agreed to divest the rights and assets related to two generic pharmaceutical products in order to settle FTC charges that its proposed $7.2 billion acquisition of Swedish drug maker Meda would be anticompetitive. The FTC order preserves competition in the markets for 250 mg generic carisoprodol tablets, which treat muscle spasms and […]